Thymic Tumor
Conditions
Interventions
The ICG injection cohort:Preoperative indocyanine green injection
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients with imaging and pathological confirmation of thymic tumors who meet the surgical indications; 2.Normal renal and hepatic function allow for tolerance of ICG angiography; 3.Age >18 and <=65 years, with the capacity to provide informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with severe complications or those who are unable to tolerate the surgery. 2.Patients with a known allergy to indocyanine green or any of its components.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Signal-to-Background Ratio; | — |
Secondary
| Measure | Time frame |
|---|---|
| The Correlation Between Tumor Stage and the Efficacy of the Fluorescence Signal Tumor-to-Background Ratio;Efficacy of Fluorescence Signal Signal-to-Background Ratio in Differentiating Benign from Malignant Thymic Lesions;Phrenic Nerve Visualization Rate;The Relationship Between Tumor Size and the Signal-to-Background Ratio of Fluorescence Signal; | — |
Countries
China
Contacts
Public ContactLi Xiao
Peking University People's Hospital
Outcome results
None listed